Corporate News tagged:
3D Cell Culture
Oct 12, 2026
REPROCELL Launches REPROSKIN™ as Both a Research Product and Contract Testing Service
REPROCELL launches REPROSKIN™, a bioengineered skin model for research and testing, offering flexibility for in-house studies or expert support.
Oct 21, 2025
REPROCELL Launches Next-Generation System for 3D Bioengineered Tissues
REPROCELL launches Alvetex® Advanced, enhancing 3D cell culture and bioengineered tissue models with improved flexibility and assay compatibility for pharmaceuticals, cosmetics, and medical device testing.
Aug 13, 2025
REPROCELL and Durham University Researchers Develop iPSC-Derived Full-Thickness Human Skin Model
REPROCELL and Durham University develop a reliable, iPSC-derived full-thickness human skin model for research and therapeutic applications, enhancing drug discovery and regenerative medicine.
Feb 13, 2020
Prof Stefan Przyborski to give Keynote Address at this year’s SMi 3D Cell Culture Conference
Read the announcement that REPROCELL Europe’s Prof Stefan Przyborski will giving the keynote address on 3D cell culture at the SMi Annual Conference London
Jan 24, 2018
REPROCELL’s Prof Stefan Przyborski to chair the SMi 2nd Annual Conference on 3D Cell Culture – London UK, 21-22 February 2018
Read the announcement that REPROCELL Europe’s CSO Prof Stefan Przyborski will chair the first day of the 3D Cell Culture conference.
Jan 19, 2018
Formation of human tissue to improve drug testing and reduce animal research
REPROCELL’s Alvetex, a scaffold for 3D cell culture and bioengineered tissue models, is in the Durham University (UK) News yesterday.
Feb 07, 2017
Scottish Enterprise Association Honours REPROCELL with Annual Awards Nomination
Read about REPROCELL CEO Dr David Bunton's nomination for the Scottish Enterprise Association Life Science Business Leadership Award
Jan 13, 2017
Prof Stefan Przyborski to chair the SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb)
The SMi Group’s 3D Cell Culture 2017 Conference (22-23 Feb) will be chaired by REPROCELL Europe’s chief scientific officer (CSO), Professor Stefan Przyborski. He will also be giving the first lecture in the conference.
Sep 16, 2016
REPROCELL Europe wins CV Technology Innovator Awards 2016 for Alvetex
REPROCELL Europe has won the Corporate Vision Technology Innovation Award 2016 for Alvetex technology for 3D cell culture.
Jul 06, 2016
Prof Stefan Przyborski speaking at BBS 2016 Biennial Meeting
ReproCELL Europe Ltd’s Chief Scientific Officer Prof Stefan Przyborski is giving a public lecture on “Scaffold Cell Culture Technology for Generation of In Vivo-like Tissue Models” at the British Biophysical Society 2016 Biennial Meeting 6th-8th July, University of Liverpool, Liverpool, UK.
May 20, 2016
REPROCELL Europe’s (formerly Reinnervate’s) CSO Prof Stefan Przyborski to give an Alvetex Seminar at the University of Oxford, 24 May 2016
Professor Stefan Przyborski, Chief Scientific Officer of REPROCELL Europe (formerly Reinnervate), is to give a seminar on Alvetex next week, 24th May 2016.
Mar 22, 2016
Reinnervate Ltd wins Corporate Vision’s 2015 Technology Innovator Award for Alvetex
We are pleased to announce that Reinnervate Ltd has been awarded Corporate Vision’s 2015 Technology Innovator Award for Alvetex 3D cell culture. Alvetex has been awarded the title, “Most Advanced 3D Cell Technology.”
Jan 14, 2016
Alvetex in Space
While the first British ESA astronaut Tim Peake is currently on the International Space Station (ISS) and is about to make his first spacewalk, now is a good time to mention again that Reinnervate’s flagship product, Alvetex® Scaffold, has been used as part of a BBSRC-funded project on the ISS in recent months.
Nov 18, 2015
Publication of Paper on “3D culture model construction of mouse neurons” in Neuroscience Letters
Reinnervate (now REPROCELL Europe) has written a paper on the topic of “3D culture model construction of mouse neurons”, along with other contributors including Durham University (UK), that has recently been published in ‘Neuroscience Letters’.
Oct 19, 2015
REPROCELL announces publication of a research report on “3D Skin Model Construction,” submitted to the International Scientific Journal “Molecular Cancer Therapeutics” by REPROCELL and others
Read more about REPROCELL CSO Professor Stefan Przyborski's latest publication on 3D Skin Model Construction published in Molecular Cancer Therapeutics
Apr 20, 2015
Alvetex® 3D cell culture platform reaches new heights with project aboard the International Space Station (ISS).
Market leading 3D cell culture company Reinnervate Ltd, part of the ReproCELL group, today announced that a rocket carrying its Alvetex® Scaffold technology blasted into Space this week. Alvetex will be used in experiments on board the International Space Station (ISS).
Oct 08, 2014
Alvetex Scaffold 384 well plates used in an Oncology HTS program by AstraZeneca
Read more about how scientists at AstraZeneca in the UK are using Alvetex Scaffold in an automated Oncology HTS (High Throughput Screening) setting.
Sep 09, 2014
REPROCELL Acquires the iPS Cell Business Unit of Stemgent, Inc. (USA)
REPROCELL announced that it will acquire the iPS Cell Business Unit of Stemgent, Inc. allowing REPROCELL to expand the product lineup of its iPSC Business
Aug 05, 2014
Stem Cell Company REPROCELL (Japan) Acquires 3D Cell Culture Company Reinnervate (UK) and Human Tissue Supplier BioServe (USA)
Read about the Japanese regenerative medicine company REPROCELL Inc. and its acquisition of Reinnervate Ltd. (UK), and BioServe Inc. of MD, USA.
Feb 05, 2014
Launch of Reinnervate Perfusion System for 3D cell culture
Read about Reinnervates announcement of the launch of a low-cost, simple system for combining 3D cell culture with dynamic circulation and perfusion of media.